New Approaches to the Drug Treatment of Schizophrenia

作者: Gavin P. Reynolds , Carole Czudek

DOI: 10.1016/S1054-3589(08)61020-0

关键词:

摘要: Publisher Summary This chapter attempts to cover the major approaches drug development for treatment of schizophrenia. In doing so, describes pharmacological rationale these and, where possible, relates this understanding neuronal basis that is still very limited, disease. At present, it apparent undesirable motor or other side effects are not required correlates antipsychotic action and in fact may reduce acceptability hence patient compliance. provides a identification improved drugs. Two further limitations current schizophrenia have expanded search more specific effective antipsychotics. Concurrent with ongoing research, recent work beginning shed light on abnormalities present brain The application quantitative histopathological techniques methods imaging provided evidence neuropathology schizophrenia, while postmortem neurochemical studies also indicated involvement neurotransmitter systems pathology. Although findings already pointers toward potential mechanisms, there way go before psychopharmacological research draws substantially from such pathological studies. It evident many cases drugs relies heuristic observation, essential mechanisms remaining obscure. Nevertheless, indicates coming closer defining those mechanisms.

参考文章(199)
Robin M. Murray, International perspectives in schizophrenia Journal of Psychosomatic Research. ,vol. 35, pp. 379- ,(1991) , 10.1016/0022-3999(91)90100-3
Herbert Y. Meltzer, Psychopharmacology : the third generation of progress Raven Press. ,(1987)
Tyrone Lee, Amar K. Sen, Receptors and ligands in psychiatry Cambridge University Press. ,(1988)
Keith Fenton Killam, Morris A. Lipton, Alberto DiMascio, Psychopharmacology : a generation of progress Raven Press. ,(1978)
FM Benes, SL Vincent, G Alsterberg, ED Bird, JP SanGiovanni, Increased GABAA receptor binding in superficial layers of cingulate cortex in Schizophrenics The Journal of Neuroscience. ,vol. 12, pp. 924- 929 ,(1992) , 10.1523/JNEUROSCI.12-03-00924.1992
Naoto Hata, Toru Nishikawa, Asami Umino, Kiyohisa Takahashi, Evidence for involvement of receptor in tonic inhibitory control of dopaminergic transmission in rat medial frontal cortex Neuroscience Letters. ,vol. 120, pp. 101- 104 ,(1990) , 10.1016/0304-3940(90)90178-C
E Meller, M Goldstein, Y Namba, K Bohmaker, A J Friedhoff, Relationship between receptor occupancy and response at striatal dopamine autoreceptors. Molecular Pharmacology. ,vol. 31, pp. 592- 598 ,(1987)
M A Geyer, D L Braff, N R Swerdlow, V A Keith, Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. Journal of Pharmacology and Experimental Therapeutics. ,vol. 256, pp. 530- 536 ,(1991)